WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark ZILBRYSQ was filed as Word mark on 09/25/2020 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1560152 |
| Countries | 
|
| Base trademark |
No. 88850346,
March 27, 2020
|
| Application date | September 25, 2020 |
| Expiration date | September 25, 2030 |
Trademark owner
87 Cambridge Park Drive
Cambridge MA 02140
US
Cambridge MA 02140
US
Trademark representatives
Drakestr. 58
12205 Berlin
DE
goods and services
05
Pharmaceutical preparations, for human use, for the
prevention and treatment of paroxysmal nocturnal
hemoglobinuria, myasthenia gravis, an inflammatory disorder,
a wound, a burn, an autoimmune disorder, a pulmonary
disorder, a cardiovascular disorder, a neurological
disorder, a kidney-related disorder, a diabetes-related
disorder, an ocular disorder, and a pregnancy-related
disorder; pharmaceutical preparations, for human use, for
the prevention and treatment of disorders of metabolism, the
nervous system, the immune system, the cardio-vascular
system, the respiratory system, the musculo-skeletal system,
and the genitourinary system; pharmaceutical preparations
for the treatment of fibrotic and inflammatory disorders;
pharmaceutical preparations for use in dermatology,
nephrology, hepatology, rheumatology, oncology, hematology
and in tissue and organ transplantation, in ophthalmology
and for gastroenterological disorders; pharmaceutical
preparations as anti-viral, anti-bacterial, or anti-fungal
agents
10
Syringes for injections; syringes for medical purposes;
syringes for medical purposes sold empty which may be filled
with pharmaceutical preparations, for human use, for the
prevention and treatment of paroxysmal nocturnal
hemoglobinuria, myasthenia gravis, an inflammatory
indication, a wound, a burn, an autoimmune indication, a
pulmonary indication, a cardiovascular indication, a
neurological indication, a kidney-related indication, a
diabetes-related indication, an ocular indication, and a
pregnancy-related indication
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 29, 2022 | 2022/17 Gaz | MX | Rejection |
| March 28, 2022 | 2022/13 Gaz | IS | Rejection |
| March 3, 2022 | 2022/10 Gaz | CA | Rejection |
| December 6, 2021 | 2021/49 Gaz | KR | Rejection |
| November 6, 2021 | 2021/46 Gaz | CO | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| November 3, 2021 | 2021/44 Gaz | BR | Rejection |
| October 14, 2021 | 2021/41 Gaz | CH | Rejection |
| September 30, 2021 | 2021/39 Gaz | NO | Rejection |
| June 29, 2021 | 2021/26 Gaz | NZ | Rejection |
| June 3, 2021 | 2021/23 Gaz | IL | Rejection |
| May 20, 2021 | 2021/21 Gaz | CO | Rejection |
| April 21, 2021 | 2021/16 Gaz | TR | Rejection |
| March 24, 2021 | 2021/12 Gaz | GB | Rejection |
| February 15, 2021 | 2021/7 Gaz | RU | Rejection |
| February 9, 2021 | 2021/6 Gaz | AU | Rejection |
| September 25, 2020 | 2020/44 Gaz | US | Registration |
ID: 141560152